Phase 2 Study of ART0380 Plus Gemcitabine in Platinum-Resistant Ovarian Cancers Begins
| Media coverage
Media coverage
Artios Pharma steps up ovarian cancer fight
| Media coverage
Silverstein appointed Chief Financial Officer at Artios Pharma
| Media coverage
Leaders at Artios explore the potential of expanding therapeutic opportunities in DDR beyond synthetic lethality
| Media coverage
Scientists uncover novel DNA repair mechanism for key cancer target
| Media coverage
Benchtop Bios Podcast featuring Dr. Graeme Smith
| Media coverage
Exciting press coverage following our Polθ (Pol-theta) press release – Nature Communications
| Media coverage
Our press coverage following our Novartis collaboration
| Media coverage
